Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Asset Writedowns and Impairment (2016 - 2025)

Genesco (GCO) has 16 years of Asset Writedowns and Impairment data on record, last reported at $3.9 million in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 2782.09% year-over-year to $3.9 million; the TTM value through Nov 2025 reached $4.8 million, up 449.48%, while the annual FY2025 figure was $1.4 million, 44.47% up from the prior year.
  • Asset Writedowns and Impairment reached $3.9 million in Q4 2025 per GCO's latest filing, up from $34000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $3.9 million in Q4 2025 and bottomed at $34000.0 in Q2 2025.
  • Average Asset Writedowns and Impairment over 5 years is $737470.6, with a median of $308000.0 recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 96.48% in 2021, then skyrocketed 2782.09% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $225000.0 in 2021, then tumbled by 42.67% to $129000.0 in 2022, then decreased by 23.26% to $99000.0 in 2023, then skyrocketed by 35.35% to $134000.0 in 2024, then surged by 2782.09% to $3.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $3.9 million in Q4 2025, $34000.0 in Q2 2025, and $890000.0 in Q1 2025.